help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology, doi:10.1210/en.2004-0488
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Aikin, R.
Right arrow Articles by Rosenberg, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Aikin, R.
Right arrow Articles by Rosenberg, L.
Endocrinology Vol. 145, No. 10 4522-4531
Copyright © 2004 by The Endocrine Society

Cross-Talk between Phosphatidylinositol 3-Kinase/AKT and c-Jun NH2-Terminal Kinase Mediates Survival of Isolated Human Islets

Reid Aikin, Dusica Maysinger and Lawrence Rosenberg

Department of Surgery (R.A., L.R.), McGill University, Montréal, Québec, Canada H3G 1A4.; and Department of Pharmacology and Therapeutics (R.A., D.M.), McGill University, Montréal, Québec, Canada H3G 1Y6

Address all correspondence and requests for reprints to: Dr. Lawrence Rosenberg, Department of Surgery, Montréal General Hospital, Room C9-128, 1650 Cedar Avenue, Montréal, Québec, Canada H3G 1A4. E-mail: lawrence.rosenberg{at}mcgill.ca.

Therapeutic strategies aimed at the inhibition of specific cell death mechanisms may increase islet yield and improve cell viability and function after routine isolation. The aim of the current study was to explore the possibility of AKT-JNK cross-talk in islets after isolation and the relevance of c-jun NH2-terminal kinases (JNK) suppression on islet survival. After routine isolation, increased AKT activity correlated with suppression of JNK activation, suggesting that they may be related events. Indeed, the increase in AKT activation after isolation correlated with suppression of apoptosis signal-regulating kinase 1 (ASK1), a kinase acting upstream of JNK, by phosphorylation at Ser83. We therefore examined whether modulators of phosphatidylinositol 3-kinase (PI3K)/AKT signaling affected JNK activation. PI3K inhibition led to increased JNK phosphorylation and islet cell death, which could be reversed by the specific JNK inhibitor SP600125. In addition, IGF-I suppressed cytokine-mediated JNK activation in a PI3K-dependent manner. We also demonstrate that inhibition of PI3K rendered islets more susceptible to cytokine-mediated cell death. SP600125 transiently protected islets from cytokine-mediated cell death, suggesting that JNK may not be necessary for cytokine-induced cell death. When administered immediately after isolation, SP600125 improved islet survival and function, even 48 h after removal of SP600125, suggesting that JNK inhibition by SP600125 may be a viable strategy for improving isolated islet survival. Taken together, these results demonstrate that PI3K/AKT suppresses the JNK pathway in islets, and this cross-talk represents an important antiapoptotic consequence of PI3K/AKT activation.




This article has been cited by other articles:


Home page
 DiabetesHome page
L. G. Grunnet, R. Aikin, M. F. Tonnesen, S. Paraskevas, L. Blaabjerg, J. Storling, L. Rosenberg, N. Billestrup, D. Maysinger, and T. Mandrup-Poulsen
Proinflammatory Cytokines Activate the Intrinsic Apoptotic Pathway in {beta}-Cells
Diabetes, August 1, 2009; 58(8): 1807 - 1815.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
D. Mokhtari, J. W. Myers, and N. Welsh
The MAPK Kinase Kinase-1 Is Essential for Stress-Induced Pancreatic Islet Cell Death
Endocrinology, June 1, 2008; 149(6): 3046 - 3053.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
M. Y. Donath, J. Storling, L. A. Berchtold, N. Billestrup, and T. Mandrup-Poulsen
Cytokines and {beta}-Cell Biology: from Concept to Clinical Translation
Endocr. Rev., May 1, 2008; 29(3): 334 - 350.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
A. Autret, S. Martin-Latil, C. Brisac, L. Mousson, F. Colbere-Garapin, and B. Blondel
Early Phosphatidylinositol 3-Kinase/Akt Pathway Activation Limits Poliovirus-Induced JNK-Mediated Cell Death
J. Virol., April 1, 2008; 82(7): 3796 - 3802.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
C.-W. Yang, W.-L. Chen, P.-L. Wu, H.-Y. Tseng, and S.-J. Lee
Anti-Inflammatory Mechanisms of Phenanthroindolizidine Alkaloids
Mol. Pharmacol., March 1, 2006; 69(3): 749 - 758.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
H. He, H.-T. Cho, W. Li, T. Kawakita, L. Jong, and S. C. G. Tseng
Signaling-Transduction Pathways Required for Ex Vivo Expansion of Human Limbal Explants on Intact Amniotic Membrane
Invest. Ophthalmol. Vis. Sci., January 1, 2006; 47(1): 151 - 157.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
C.-Y. Lin, T. Gurlo, L. Haataja, W. A. Hsueh, and P. C. Butler
Activation of Peroxisome Proliferator-Activated Receptor-{gamma} by Rosiglitazone Protects Human Islet Cells against Human Islet Amyloid Polypeptide Toxicity by a Phosphatidylinositol 3'-Kinase-Dependent Pathway
J. Clin. Endocrinol. Metab., December 1, 2005; 90(12): 6678 - 6686.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
Z. R. Healy, N. H. Lee, X. Gao, M. B. Goldring, P. Talalay, T. W. Kensler, and K. Konstantopoulos
Divergent responses of chondrocytes and endothelial cells to shear stress: Cross-talk among COX-2, the phase 2 response, and apoptosis
PNAS, September 27, 2005; 102(39): 14010 - 14015.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
J. J. Song and Y. J. Lee
Cross-talk between JIP3 and JIP1 during Glucose Deprivation: SEK1-JNK2 AND Akt1 ACT AS MEDIATORS
J. Biol. Chem., July 22, 2005; 280(29): 26845 - 26855.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
F. Pelisch, M. Blaustein, A. R. Kornblihtt, and A. Srebrow
Cross-talk between Signaling Pathways Regulates Alternative Splicing: A NOVEL ROLE FOR JNK
J. Biol. Chem., July 8, 2005; 280(27): 25461 - 25469.
[Abstract] [Full Text] [PDF]

Home page
 JCBHome page
J. J. Song and Y. J. Lee
Dissociation of Akt1 from its negative regulator JIP1 is mediated through the ASK1-MEK-JNK signal transduction pathway during metabolic oxidative stress: a negative feedback loop
J. Cell Biol., July 4, 2005; 170(1): 61 - 72.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
R. Wang, J. Li, K. Lyte, N. K. Yashpal, F. Fellows, and C. G. Goodyer
Role for {beta}1 Integrin and Its Associated {alpha}3, {alpha}5, and {alpha}6 Subunits in Development of the Human Fetal Pancreas
Diabetes, July 1, 2005; 54(7): 2080 - 2089.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
P. Rao, J. Roccisana, K. K. Takane, R. Bottino, A. Zhao, M. Trucco, and A. Garcia-Ocana
Gene Transfer of Constitutively Active Akt Markedly Improves Human Islet Transplant Outcomes in Diabetic Severe Combined Immunodeficient Mice
Diabetes, June 1, 2005; 54(6): 1664 - 1675.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
N. K. Yashpal, J. Li, M. B. Wheeler, and R. Wang
Expression of {beta}1 Integrin Receptors during Rat Pancreas Development--Sites and Dynamics
Endocrinology, April 1, 2005; 146(4): 1798 - 1807.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2004 by The Endocrine Society